Explore News
-
Weight-loss drugs cut cancer risk by up to 30%
New research indicates weight-loss medications could be a valuable tool in cancer prevention
-
1 in 3 on GLP-1s Now Buy More Fragrances, Study Hints
Patients on GLP-1 drugs like Ozempic and Wegovy increasingly report heightened smell sensitivity and a…
-
How Weight-Loss Jabs Are Redefining Beauty Standards
As GLP-1 drugs like Wegovy and Mounjaro surge in popularity, cultural perceptions of attractiveness are…
-
GLP-1 Drugs Show Promise Against Arthritis: 70% Lower Joint Inflammation
New research shows GLP-1 receptors in arthritic joints, suggesting drugs like Wegovy may directly reduce…
-
How the Pill Form of Wegovy Could Transform Weight Loss Care
The European Medicines Agency’s green light marks a pivotal shift in obesity treatment, offering millions…
-
Obesity Drugs Cut Asthma Attacks by 26%, Study Reveals
New research shows GLP-1 drugs are associated with significantly fewer asthma flare-ups and reduced reliance…
-
Weight-Loss Jabs Cut Sickness Absence by 50%, NHS Study Reveals
A nine-month UK trial shows GLP-1 medications reduced long-term sickness absence by over half, with…
-
Why GLP-1 Weight-Loss Drugs May Be Safe During Pregnancy
New research suggests Ozempic and similar medications do not pose a significant threat








